APA (7th ed.) Citation

Soltek, S., Karakhanova, S., Serba, S., & Bazhin, A. V. (2015). Anti-tumor properties of the cGMP/protein kinase G inhibitor DT3 in pancreatic adenocarcinoma. Naunyn-Schmiedeberg's archives of pharmacology, 388(11), . https://doi.org/10.1007/s00210-015-1147-9

Chicago Style (17th ed.) Citation

Soltek, Sabine, Svetlana Karakhanova, Susanne Serba, and Alexandr V. Bazhin. "Anti-tumor Properties of the CGMP/protein Kinase G Inhibitor DT3 in Pancreatic Adenocarcinoma." Naunyn-Schmiedeberg's Archives of Pharmacology 388, no. 11 (2015). https://doi.org/10.1007/s00210-015-1147-9.

MLA (9th ed.) Citation

Soltek, Sabine, et al. "Anti-tumor Properties of the CGMP/protein Kinase G Inhibitor DT3 in Pancreatic Adenocarcinoma." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 388, no. 11, 2015, https://doi.org/10.1007/s00210-015-1147-9.